Behzad Aghazadeh is venBio Select Advisor's portfolio manager. venBio returned more than 60% during the first 11 months of 2014.
| Fund Name: | VenBio Select Advisor |
| Manager | Behzad Aghazadeh |
| Portfolio Value | $6,858,151,355 |
| Change This QTR | +0.91% |
| No. | Security | Ticker | Shares | Value | Activity | % Port | History |
|---|---|---|---|---|---|---|---|
| 1. | UTHR | 2,858,888 | $1,024,482,515 | 14.93% | |||
| 2. | ASND | 4,988,888 | $744,890,867 | +19% | 10.86% | ||
| 3. | ARGX | 1,238,467 | $671,348,191 | 9.78% | |||
| 4. | KRYS | 2,622,222 | $477,323,071 | +8% | 6.95% | ||
| 5. | Madrigal Pharmaceuticals Inc. | 2,029,000 | $430,594,380 | -2% | 6.27% |
| Symbol | Company | Filed By | Filing Date | Filing |
|---|---|---|---|---|
| 2024-04-23 | ||||
| 2024-02-14 | ||||
| 2024-02-14 | ||||
| 2024-02-14 | ||||
| 2024-02-14 |
